Tumor Ablation Market Size To Reach $6.10 Billion By 2033

January 2026 | Report Format: Electronic (PDF)

Tumor Ablation Market Growth & Trends

The global tumor ablation market size is expected to reach USD 6.10 billion by 2033, registering a CAGR of 14.1% from 2026 to 2033, according to a new report by Grand View Research, Inc. An increasing incidence of cancer and high demand for effective treatment options are the major factors contributing to market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020, and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported. The growing preference for minimally invasive procedures, attributed to advantages like fast recovery, patient comfort, and shorter turnaround times, is projected to drive demand for advanced tumor ablation techniques.

Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.

key Request a free sample copy or view report summary: Tumor Ablation Market Report

Tumor Ablation Market Report Highlights

By technology, the radiofrequency ablation segment held the highest market share of 32.9% in 2025. The microwave ablation segment is expected to witness the fastest CAGR of 14.9% over the forecast period.
By treatment, the percutaneous ablation segment held a leading market share in 2025. The laparoscopic ablation segment is expected to witness the fastest CAGR over the forecast period.
By application, the liver cancer segment held a leading market share in 2025. The lung cancer segment is anticipated to grow at the fastest CAGR over the forecast period.
North America's tumor ablation market held the largest share of 42.4% of the global market in 2025. The U.S. tumor ablation industry is expected to grow significantly over the forecast period.